HRP990402C1 - Farmaceutski pripravci za primjenu na sluznici - Google Patents

Farmaceutski pripravci za primjenu na sluznici

Info

Publication number
HRP990402C1
HRP990402C1 HR990402A HRP990402A HRP990402C1 HR P990402 C1 HRP990402 C1 HR P990402C1 HR 990402 A HR990402 A HR 990402A HR P990402 A HRP990402 A HR P990402A HR P990402 C1 HRP990402 C1 HR P990402C1
Authority
HR
Croatia
Prior art keywords
mucosa
application
pharmaceutical compositions
mosm
medicaments
Prior art date
Application number
HR990402A
Other languages
English (en)
Inventor
Nishibe Yoshihisa
Kinoshita Wataru
Kawabe Hiroyuki
Original Assignee
Teijin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26450407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP990402(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Limited filed Critical Teijin Limited
Publication of HRP990402A2 publication Critical patent/HRP990402A2/hr
Publication of HRPK990402B1 publication Critical patent/HRPK990402B1/hr
Publication of HRP990402C1 publication Critical patent/HRP990402C1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Vodeni farmaceutski pripravak za primjenu na sluznicu, naznačen time što sadrži jednu ili više tvari koje su netopljive i/ili slabo topljive u vodi, te jedan ili više medikamenata, te ima osmotski tlak od 150 mOsm ili manje. Patent sadrži još 31 patentni zahtjev.
HR990402A 1998-04-21 1999-12-22 Farmaceutski pripravci za primjenu na sluznici HRP990402C1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11088798 1998-04-21
JP11088898 1998-04-21
PCT/JP1999/002126 WO1999053899A1 (fr) 1998-04-21 1999-04-21 Compositions medicinales a appliquer sur la muqueuse

Publications (3)

Publication Number Publication Date
HRP990402A2 HRP990402A2 (en) 2000-04-30
HRPK990402B1 HRPK990402B1 (hr) 2001-08-31
HRP990402C1 true HRP990402C1 (hr) 2008-09-30

Family

ID=26450407

Family Applications (1)

Application Number Title Priority Date Filing Date
HR990402A HRP990402C1 (hr) 1998-04-21 1999-12-22 Farmaceutski pripravci za primjenu na sluznici

Country Status (36)

Country Link
US (3) US6939559B1 (hr)
EP (1) EP0998916B1 (hr)
JP (2) JP5142420B2 (hr)
KR (1) KR100686901B1 (hr)
CN (1) CN1304052C (hr)
AT (1) ATE336986T1 (hr)
AU (1) AU757772B2 (hr)
BG (1) BG64919B1 (hr)
BR (1) BRPI9906372B8 (hr)
CA (1) CA2294457C (hr)
CY (1) CY1105771T1 (hr)
CZ (1) CZ298466B6 (hr)
DE (1) DE69932905T2 (hr)
DK (1) DK0998916T3 (hr)
EA (1) EA002967B1 (hr)
EE (1) EE05072B1 (hr)
ES (1) ES2272064T3 (hr)
GE (1) GEP20022669B (hr)
GT (2) GT199900180A (hr)
HR (1) HRP990402C1 (hr)
HU (1) HU226712B1 (hr)
ID (1) ID24818A (hr)
IL (1) IL133614A (hr)
IS (1) IS2453B (hr)
NO (1) NO328270B1 (hr)
NZ (1) NZ501950A (hr)
PL (1) PL197875B1 (hr)
PT (1) PT998916E (hr)
RS (1) RS49764B (hr)
SI (1) SI0998916T1 (hr)
SK (1) SK286101B6 (hr)
TR (1) TR199903193T1 (hr)
TW (1) TWI243687B (hr)
UA (1) UA77640C2 (hr)
WO (1) WO1999053899A1 (hr)
ZA (1) ZA997727B (hr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261836B1 (en) * 1996-10-01 2001-07-17 Geron Corporation Telomerase
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
CN1674916A (zh) * 2002-08-30 2005-09-28 奥坦纳医药公司 环缩松与抗组胺药的组合用于治疗变应性鼻炎的用途
US20060216245A1 (en) * 2002-12-10 2006-09-28 Showa Yakuhin Kako Co., Ltd. Composition for local anesthesia
JP4755495B2 (ja) * 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP4128521B2 (ja) * 2003-12-19 2008-07-30 信越化学工業株式会社 ゲル状シート及びその製造方法
US20090215898A1 (en) 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
DE602005015506D1 (de) * 2004-04-28 2009-09-03 Shinetsu Chemical Co Filmzubereitung und Verfahren zu deren Herstelllung
US20070231396A1 (en) * 2006-03-29 2007-10-04 Ray Charles D Medication spray formulation
EP2265250A2 (en) * 2008-03-14 2010-12-29 Cephalon, Inc. Enhanced transmucosal composition and dosage form
PL2445472T3 (pl) * 2009-06-24 2018-07-31 Lipoid Gmbh Kompozycja do zastosowań kosmetycznych, farmaceutycznych lub dietetycznych
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
US9504736B2 (en) 2010-09-23 2016-11-29 The Regents Of The University Of California Administration of serine protease inhibitors to the stomach
WO2012093087A1 (de) * 2011-01-05 2012-07-12 Michael Tchirikov Hypotone wässrige zusammensetzung mit verringertem chloridgehalt mit oder ohne phospholipide
ES2375784B1 (es) 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
DK3122349T3 (da) 2014-03-25 2022-02-14 Leading Biosciences Inc Sammensætninger til behandling af autodigestion
CN104473864B (zh) * 2014-11-25 2017-02-22 陈长潭 一种卡络磺钠半固体制剂及其制备方法
EP3369429B1 (en) 2015-10-30 2019-12-11 Teijin Pharma Limited Pharmaceutical composition intended to be administered to nasal mucosa
BE1025996A9 (fr) 2018-01-19 2020-05-11 Hyloris Dev Sa Solution orale d’acide tranexamique
WO2022065404A1 (ja) * 2020-09-25 2022-03-31 アステラス製薬株式会社 耳内投与用の医薬組成物
EP4062919A1 (de) 2021-03-24 2022-09-28 Prenatal International GmbH Eine oder mehrere zusammensetzungen auf basis des menschlichen fruchtwassers zur anwendung in einem verfahren zur enteralen ernährung, zur enteralen ernährungsergänzung und/oder zur behandlung und/oder versorgung von kapillararmen schichten

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
IL70489A0 (en) 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB8514090D0 (en) 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS6034925A (ja) * 1983-08-04 1985-02-22 Mitsubishi Chem Ind Ltd ２−ヒドロキシイソフタルアルデヒド類の製造法
WO1985002092A1 (en) 1983-11-14 1985-05-23 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
JPS60123426A (ja) * 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
JPS60224616A (ja) 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPS63303031A (ja) 1987-05-30 1988-12-09 Nippon Piston Ring Co Ltd コンプレッサ用ベ−ン
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
EP0308181A1 (en) * 1987-09-14 1989-03-22 Novo Nordisk A/S Trans-mucosal delivery formulations and a method for preparation thereof
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
DE69014081T2 (de) 1989-10-31 1995-03-30 Columbia Laboratories, Inc., Miami, Fla. Mittel zur Feuchthaltung vaginalen Gewebes.
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
DK0578780T3 (da) 1991-04-03 2003-08-18 Univ Vanderbilt Sænkning af thromboxanniveauer ved perkutan indgivelse af aspirin
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
KR100281609B1 (ko) * 1991-12-27 2001-02-15 폴락 돈나 엘. 유효 제제를 포함하는 분산액의 동일 반응계내 생성 및 방출을 조절하는 약물 전달 장치
CN1075081A (zh) * 1992-02-01 1993-08-11 解放军陆军第44医院 复方胶体麻醉剂的配制方法
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) * 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
DK0943326T4 (da) 1996-02-27 2007-01-22 Teijin Ltd Pulveragtigt præparat til nasal administration
JPH09253220A (ja) 1996-03-26 1997-09-30 Kaajiopeeshingu Res Lab:Kk 生体内に植え込み可能なリード
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
RU2111829C1 (ru) 1996-10-09 1998-05-27 Буркин Сергей Павлович Способ непрерывного получения тонкой металлической полосы и машина для его осуществления
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
JP4009355B2 (ja) 1997-10-02 2007-11-14 村樫石灰工業株式会社 芝草地に発生するコケ・藻類の防除用組成物及び防除方法

Also Published As

Publication number Publication date
CZ460499A3 (cs) 2000-05-17
SI0998916T1 (sl) 2007-02-28
NO328270B1 (no) 2010-01-18
KR20010014067A (ko) 2001-02-26
EA002967B1 (ru) 2002-12-26
PL337534A1 (en) 2000-08-28
EP0998916B1 (en) 2006-08-23
IL133614A (en) 2004-12-15
CZ298466B6 (cs) 2007-10-10
UA77640C2 (uk) 2007-01-15
DK0998916T3 (da) 2006-12-11
PT998916E (pt) 2006-12-29
HRPK990402B1 (hr) 2001-08-31
IS5312A (is) 1999-12-20
SK182399A3 (en) 2000-07-11
WO1999053899A1 (fr) 1999-10-28
NO996323D0 (no) 1999-12-20
HU226712B1 (en) 2009-07-28
GT199900180AA (es) 2006-08-29
ATE336986T1 (de) 2006-09-15
BG64919B1 (bg) 2006-09-29
EE9900589A (et) 2000-08-15
PL197875B1 (pl) 2008-05-30
CA2294457A1 (en) 1999-10-28
RS49764B (sr) 2008-04-04
HRP990402A2 (en) 2000-04-30
EE05072B1 (et) 2008-10-15
BG104020A (en) 2000-05-31
YU54499A (sh) 2002-06-19
JP2004099624A (ja) 2004-04-02
HUP0002512A3 (en) 2001-03-28
TR199903193T1 (xx) 2000-11-21
CY1105771T1 (el) 2011-02-02
CN1272784A (zh) 2000-11-08
GT199900180A (es) 2001-12-18
US7235247B2 (en) 2007-06-26
ZA997727B (en) 2000-10-12
US20030008019A1 (en) 2003-01-09
DE69932905T2 (de) 2007-04-05
BR9906372A (pt) 2000-07-11
AU757772B2 (en) 2003-03-06
DE69932905D1 (de) 2006-10-05
NO996323L (no) 2000-02-18
US6939559B1 (en) 2005-09-06
GEP20022669B (en) 2002-04-25
BRPI9906372B1 (pt) 2015-09-01
BRPI9906372B8 (pt) 2021-05-25
AU3534399A (en) 1999-11-08
KR100686901B1 (ko) 2007-02-26
US20050181054A1 (en) 2005-08-18
IS2453B (is) 2008-11-15
JP5142420B2 (ja) 2013-02-13
CN1304052C (zh) 2007-03-14
IL133614A0 (en) 2001-04-30
SK286101B6 (sk) 2008-03-05
NZ501950A (en) 2003-04-29
ES2272064T3 (es) 2007-04-16
HUP0002512A2 (hu) 2000-12-28
EA200000060A1 (ru) 2000-08-28
EP0998916A4 (en) 2002-06-19
CA2294457C (en) 2008-06-17
ID24818A (id) 2000-08-24
EP0998916A1 (en) 2000-05-10
TWI243687B (en) 2005-11-21

Similar Documents

Publication Publication Date Title
HRPK990402B1 (hr) Farmaceutski pripravci za primjenu na sluznici
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
RS50310B (sr) Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži
ATE213405T1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
HRP20020880B1 (hr) Novi farmaceutski pripravak
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
ME00568B (me) Vodena farmaceutska kompozicija koja sadrži ciklesonid
KR950013496A (ko) 구강용 겔조성물
JPS57118509A (en) Novel preparation of high absorbability
MY124416A (en) Pharmaceutical composition for application to mucosa
TH7163A (th) ส่วนประกอบแชมพู
TH56262B (th) สารผสมทางเภสัชกรรมที่มีคลีโซไนด์สำหรับการใช้ที่เยื่อบุ
ES2179791B1 (es) Nueva formulacion cosmetica a base de mucilagos de origen natural (vegetal) obtenidos de la guazima (guazuma ulmifolia lam.) para aplicacion topica percutanea.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
C1B1 Converted consensual patent
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180329

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190421